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II.  Abbreviations 
 
 
ARVO    Association for Research in Vision and Ophthalmology 
BM   Bruch Membrane 
CNG    CyclicNucleotide-Gated 
CNS    Central Nervous System 
CRB   Crumbs protein 
cSLO    confocal Scanning Laser Ophthalmoscopy 
ERG    Electroretinography 
GCL    Ganglion Cell Layer 
I/OS   Inner/Outer Segment border 
ILM   Inner Limiting Membrane 
INL    Inner Nuclear Layer 
IPL    Inner Plexiform Layer 
IS   Inner Segment 
KO    Knock-Out 
LCA   Leber’s Congenital Amaurosis 
NHP   Non-human primates 
OLM    Outer Limiting Membrane 
ONL    Outer Nuclear Layer 
OPL    Outer Plexiform Layer 
OS    Outer Segment 
PN    Post-Natal day 
RP    Retinitis Pigmentosa 
RPE    Retinal Pigmented Epithelium 
SD-OCT   Spectral Domain Optical Coherence Tomography 
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III. SUMMARY 
 
Human inherited retinal degenerative disorders exhibit a large genetic and phenotypic 
heterogeneity. Retinitis Pigmentosa (RP), one of the most severe forms, denotes a group of 
hereditary disorders of the rod system that cause progressive retinal degeneration and may 
eventually lead to blindness. Achromatopsia is characterized by a total loss of function of all 
cone photoreceptors in the retina, leading to a severe visual impairment. So far, no cure or 
scientifically proven symptomatic treatment has been found for neither RP nor 
Achromatopsia. Because the full course of the disease is difficult to follow in patients, the 
availability of genetically engineered animal models is instrumental to uncover the 
pathophysiological mechanisms underlying the disease. 
 
The aim of this project was to apply and further develop retinal imaging technology in order 
to refine in vivo structural information as a basis to better understand the mechanisms of the 
pathophysiology associated with inherited retinal diseases. Particularly within the scope of 
this thesis, major advances have been made in an early-onset form of RP called Leber’s 
Congenital Amaurosis (LCA) and two photoreceptor channelopathies that affect the rod and 
the cone system, respectively. This is complemented by the development of novel structural 
biomarkers for the follow-up of therapeutic strategies in both rod- and cone-centered disease 
classes. 
 
The first part of the thesis introduces recent insights in the mechanisms of interaction of 
Crumbs proteins and the potential exchangeability of the different forms by means of 
respective mouse models: Crb1-/-, Crb2-/- and the Crb1Crb2 double knock-out mouse. It has 
been found that the lack of Crb1 resulted in a partial degeneration of the retina, whereas the 
lack of Crb2 induced a severe retinal degeneration similar to that of Retinitis Pigmentosa. 
The simultaneous ablation of both proteins mimics the characteristic retinal degeneration 
pattern showed by Leber Congenital Amarosis type (LCA) patients. This work has led to 
substantial progress in the field and several publications in a number of high-ranking journals 
(publication list 2,5,9,17,18).  
 
The second part addresses the work on the restoration of function and morphology in a 
mouse model of Retinitis Pigmentosa or Achromatopsia, lacking the Cngb1 and Cnga3 
proteins, respectively. Both approaches were performed by means of an adeno-associated 
viral (AAV) therapy. For the short –and long term assessment of therapeutic effects, novel 
morphological biomarkers based on optical coherence (OCT) data were develop. This work 
was documented in Koch et. al. 2012 and in Mühlfriedel et al. 2013.  
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The third part is devoted to the expansion of the diagnostic repertoire by improved, more 
informative biomarkers for therapy assessment beyond the state-of-the-art. The work is 
based on OCT, a novel technique for the in vivo visualization of retinal layers. Here, a 
quantitative method for a more detailed description of the retinal structure by means of 
reflectivity profiles was designed. This method was verified in three common laboratory 
species with differences in retinal architechture. Finally, the problem of unequal scales for the 
measurement of two-dimensional structures was resolved. Intraocular objects of known 
dimensions in the murine eye were used for the equal calibration of axes in OCT images. 
This work was reported in Garcia Garrido et al. 2014 and Garcia Garrido et al. 2015. 
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IV. ZUSAMMENFASSUNG 
 
Erbliche Neutzhauterkrankungen weisen eine umfangreiche genetische und phänotypische 
Heterogenität auf. Als eine der häufigsten und schwersten Formen umfasst Retinitis 
Pigmentosa (RP) eine Gruppe von erblichen Erkrankungen, die zur progressiven 
Degeneration der Netzhaut und zur totalen Erblindung führen können. Achromatopsie ist 
charakterisiert durch einen totalen Funktionsverlust der Zapfen in der Netzhaut, der zu einer 
schweren visuellen Beeinträchtigung führt. Bisher konnte weder für RP noch für  
Achromatopsie eine erfolgreiche Therapie entwickelt werden. Aufgrund der Komplexität des 
Krankheitsverlaufs gestaltet sich eine Untersuchung am Menschen als sehr schwierig. Daher 
wurden in den letzten Jahren  genetisch veränderte Tiermodelle eingesetzt, die maßgeblich 
dazu beigetragen haben, die zugrunde liegenden pathophysiologischen Mechanismen zu 
verstehen. 
 
Das Ziel dieser Dissertation ist die Anwendung und Weiterentwicklung der retinalen 
Bildgebungstechnologie, um detailliertere in vivo Strukturinformationen zu erhalten, die das 
Verständnis der Pathophysiologie von erblichen Netzhauterkrankungen erweitern. Im 
Rahmen dieser Arbeit wurden sowohl große Fortschritte auf dem Forschungsgebiet der 
Leber’schen kongenitalen Amaurose (LCA), eine frühzeitig einsetzende Form der RP, als 
auch auf dem Gebiet der Erforschung defekter Kanalfunktionen, die sowohl das Stäbchen- 
als auch das Zapfensystem betreffen, gemacht. Zusätzlich wurden während der Dissertation 
neuartige strukturelle in vivo Biomarker generiert, die für die Evaluation von therapeutischen 
Strategien bei verschiedenen Stäbchen- und Zapfenerkrankungen angewendet werden 
können. 
 
Der erste Teil der Arbeit befasst sich mit der Interaktion von Membranproteinen aus der 
Crumbsfamilie bei Netzhauterkrankungen. Dabei wurde spezifisch die Redundanz der 
unterschiedlichen Crumbsvarianten anhand entsprechender Mausmodelle (Crb1-/-, Crb2-/- 
und die Crb1Crb2 Doppelmutante) untersucht. Es wurde bereits gezeigt, dass der Verlust 
von Crb1 zu einer partiellen Netzhautdegeneration führt, wohingegen der Mangel an Crb2 
eine RP ähnliche Netzhautdegeneration zur Folge hat. Der gleichzeitige Verlust von beiden 
Proteinen ähnelt dem Degenerationsmuster, das bei LCA Patienten beobachtet wurde. Die 
vorliegende Arbeit hat bedeutende Erkenntnisse zur Erforschung dieser Erkrankungen 
beigetragen und zu einer Vielzahl an hochrangigen Veröffentlichungen geführt 
(Publikationsliste 2,5,9,17,18). 
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Im zweiten Teil der Arbeit stehen gentherapeutische Ansätze bei Mausmutanten, die den 
Phänotyp der RP bzw. Achromatopsie aufweisen, im Fokus. Dabei wurde eine Adenovirus-
assoziierte (AAV) Therapie eingesetzt, die jeweils die Kanalproteine Cngb1 bzw. Cnga3 
exprimieren und zur Wiederherstellung der Funktion und Morphologie der Photorezeptoren in 
den entsprechenden Mausmutanten führen. Zur Bewertung der kurz- und langfristigen 
therapeutischen Effekte wurden neuartige morphologische Biomarker, die auf Daten der 
Optischen Kohärenztomographie (OCT) basieren entwickelt. Ein Großteil der Ergebnisse 
wurde bereits in Koch et al. 2012 und in Mühlfriedel et al. 2013 beschrieben. 
 
Der dritte Teil beinhaltet die Weiterentwicklung von aufschlussreicheren Biomarkern für die 
Bewertung von Therapieansätzen, um die aktuelle Diagnostik-Technologie zu erweitern. 
Dafür wurde die OCT um eine quantitative Methode erweitert, die die Struktur der Netzhaut 
mittels Reflektivitätsprofile beschreibt. Die Methode wurde in drei experimentellen Spezies 
mit einem unterschiedlichen Retinaaufbau verifiziert. In einem abschließenden Ansatz wurde 
die Problematik der geräteabhängigen ungleichen Maßstäbe für die Messung 
zweidimensionaler Objekte gelöst. Dafür wurden intraokulare Objekte im Mausauge mit 
bekannten Abmessungen verwendet, um eine gleichmäßige Kalibrierung der Achsen im 
OCT-Bild zu erreichen. Die Ergebnisse wurden in Garcia Garrido et al. 2014 und in Garcia 
Garrido et al. 2015 beschrieben. 
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INTRODUCTION 
 
Vision starts in the retina which is located at the posterior part of the eye. “Rete”, the Latin 
origin of its name standing for “net”, connotes with two important properties, a two-
dimensional layer structure and a multitude of connections. Vision begins when the light hits 
the retinal photoreceptors - rods and cones – and they transform it into an electrical signal 
which is rapidly processed by a network of horizontal, bipolar and amacrine cells and is 
further sent it to the brain along the optic nerve. Information from the optic nerve (of each 
eye) is then combined at the level of the chiasm and is afterwards divided, according to the 
visual field in a right and left optic tract. The optic tract reaches the neurons at the lateral 
geniculate nucleus in the thalamus which finally conducts the visual information to the 
primary visual cortex in the brain (Rodieck 1998). 
 
 
 
Figure 1. From the retina to the visual cortex 
 
 
1.1.  Anatomy of the eye 
 
The human eye has a very similar structure to that of other vertebrate animals. It possesses 
a lens, adjustable depending on the distance, and a pupil, which acts as a diaphragm 
regulated by the iris. The retina is the light-sensitive tissue.  
The anterior part of the eye is divided in two compartments: the anterior chamber, located 
between the cornea and the iris, and the posterior chamber, located between the iris and the 
lens. The pressure in these chambers is regulated by the presence of a clear liquid called 
humour aqueous. Between the lens and the retina there is the vitreous body which has the 
consistency of a gel. These structures are finally coated by three layers. The most external 
layer is known as the fibrous tunic and it is composed by the cornea and the sclera. The 
layer in the middle is known as the vascular tunic or uvea and consists of the choroid, ciliary 
  - 10 -
body and the iris. The most internal layer is the nervous tunic or retina (Levin and Kaufman 
2011, Dowling 2012). 
 
 
 
Figure 2. The human eye (modified from Novartis Pharma Schweiz AG) 
 
 
1.2.  Anatomy of the retina 
 
The retina is a transparent layered tissue composed by ten underlying layers, and these from 
the most external to the most internal part are: (Ebrey and Koutalos 2001) (Anatomia Ocular 
p.24, Dr. E. Garcia Garrido). 
 
 Retinal Pigmented Epithelium (RPE): The RPE is a single layer of cuboidal cells 
that serves some of the metabolic needs of the photoreceptors and acts as a barrier 
to ions and many molecules. The basal site is in touch with the Bruch’s membrane 
(BM) and the apical site sends out microvilli towards the outer segments of the 
photoreceptors (PR). These cells contain a pigment called melanin (in the apical side) 
which strongly absorbs the light through the visible spectrum, and lipofuscine, which 
is originated from the phagocytic activity of these cells. 
 Photoreceptor layer: Photoceptors are light-sensitive cells and they contain a 
chromophore (11-cis retinal) bound to a cell membrane protein, opsin, and this 
enables the visual phototransduction. There are two types of photoreceptors: cones 
and rods. Rods are very sensitive to light and are the primary source of visual 
information in darkness (scotopic vision). They are spread over the fundus except of 
the fovea. Their opsin is called rhodopsin. Cones are less sensitive to light than rods 
but they are responsible for color vision. They are densely located in the fovea but 
their number diminishes when reaching the periphery. There are three types of cones, 
each of them with a different pigment, namely: L, M and S-cones, sensitive at 
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different wavelengths (long, mid and short wavelengths correspond to red, green and 
blue, respectively). 
 
Figure 3. Photoreceptor cells (modified from (Werner and Chalupa 2014) 
 
 
 Outer Limiting Membrane (OLM): is not a real membrane, it represents the 
adherens junctions between photoceptor cells and Müller glia cells and it separates 
the inner segment from the photoceptor nuclei. 
 Outer Nuclear Layer (ONL): is the layer that contains the nuclear bodies of rod and 
cone photoreceptor cells. 
 Outer Plexiform Layer (OPL): represents the synaptic connections between 
photoceptor projections and the dentrites of bipolar and horizontal cells. 
 Inner Nuclear Layer (INL): contains the nuclei of bipolar, horizontal and amacrine 
cells. 
 Inner Plexiform Layer (IPL): contains the synapse between the axons of the bipolar 
cells and the dendrites of the ganglion cells. 
 Ganglion Cell Layer (GCL): contains the nuclei of the ganglion cells. 
 Nerve Fibre Layer (NFL): contains the axons of the ganglion cells which form the 
optic nerve. 
 Inner Limiting Membrane (ILM): basement membrane that separates the retina from 
the vitreous. 
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Figure 4. Schematic organization of the retina (modified from (Swaroop et al. 2010)
 A: amacrine; B: bipolar; C: cone; G: ganglion; H: horizontal; M: Müller; R: rod. 
 
 
1.3. Inherited retinal disorders 
 
Human inherited retinal degenerative disorders exhibit a large genetic and phenotypic 
heterogeneity. Retinitis Pigmentosa (RP), one of the most severe forms and with a 
prevalence of 1:4000 (Zobor and Zrenner 2012), belongs to the group of hereditary disorders 
of the rod system that cause progressive retinal degeneration and can lead to blindness 
(Hamel 2006). So far, more than 45 genes have been associated to RP. Mutations in those 
genes can lead to a reduction or abolishment of the functionality of the corresponding protein 
which is necessary for the photoreceptor cells, the RPE, the intracellular transduction 
cascade, the cilliary transport or the ion exchange. The onset of the disease, the progression 
and the magnitude of the affected retinal area, mostly depend on the inheritance pattern and 
the genotype of the individual (Kellner et al. 2004). RP can arise as an autosomal-dominant, 
autosomal recessive, x-chromosomic, mitochondrial isolated disease or syndromic e.g. 
Usher-Syndrome or Bardet-Biel-Syndrome (Zobor and Zrenner 2012). The clinical profile in 
affected individuals may further vary depending on the size and location of the damage in the 
retina. However, some of the common symptoms are: 
 
- Nyctalopia or night blindness 
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- Loss of mid-peripheral vision, which progressively extends to both centre and 
periphery 
- Aversion to glare 
- Reduced colour vision  
- Slow adaptation time 
- Blurred vision and poor colour separation 
 
 
 
Figure 5. Different stages in RP.  Changes in retinal architecture of the retina (modified from 
Jacobson et al. N ENG J MED 363; 17.(Jacobson and Cideciyan 2010)) 
 
 
Leber’s Congenital Amaurosis denotes a group of inherited retinal disorders that appear at 
birth or within the first months of life and it has a prevalence of 1 to 80000 (Stone 2007). It 
can be associated with different genes, and those encode proteins with different functions as 
photoreceptor morphogenesis, photransduction and ciliary transport (Walia et al. 2010). 
Patients typically suffer from nystagmus, non-detectable or severely reduced rod and cone 
electroretinogram , and a poor visual acuity. 
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1.4. Retinal imaging methods 
 
The retina is an offshoot of the developing brain and it is considered as a component of the 
central nervous system (CNS). However, it is the only part of the brain that can be visualized 
non-invasively. (Sensory reception: Human vision: structure and function of the human eye” 
vol 27, Encyclopaedia Britannica, 1987). 
Thus, the retina –as part of the brain- can serve to visualize not only ocular diseases, such 
as age-related macular degeneration, glaucoma or retinitis pigmentosa but also systemic 
diseases that may also show manifestations in the retina, as for example diabetes or 
hypertension (Dowling 2012). For this reason, several imaging diagnostic techniques are 
available (Abramoff et al. 2010). 
 
1.4.1. Scanning laser ophthalmoscopy (SLO) 
 
SLO is an in vivo diagnostic technique for imaging the eye which uses specific laser 
wavelengths. Shorter wavelengths (blue-green) are generally more strongly absorbed by 
ocular structures -especially melanin granules in the retinal pigment epithelium (RPE) and 
choroid- than longer wavelengths (near infrared) (Preece and Claridge 2002). In 
consequence, lasers in the short wavelength range provide higher contrast images of the 
retina but are unable to penetrate the RPE/choroid, whereas the infrared lasers give less 
retinal details but can pass through the choroid down to the sclera (Seeliger et al. 2005). The 
488 nm wavelength is used for fundus autofluorescence (FAF) analyses, which reveals the 
presence of natural fluorophores in the retina and the RPE (Schmitz-Valckenberg et al. 
2008). 
 
In addition, fluorescent dyes excitable in the blue and infrared range offer a unique access to 
the vascular structures associated with the eye. Fluorescein (FL) is a dye that emits light 
when excited at a wavelength of 488 nm. To allow only the light emitted by the dye upon 
stimulation to become visible, a barrier filter at 500 nm is used to remove the light associated 
with the excitation. Fluorescein angiography (FLA) provides the most detailed images of 
retinal capillaries (Seeliger et al. 2005). Indocyanine green (ICG) is a dye that emits light at 
800 nm and above when excited at a wavelength of 795 nm. Similar to FLA, a barrier filter at 
800 nm is used to remove the light associated with the excitation. Therefore, ICGA provides 
information about choroidal vessels. 
 
In this research work, a HRA I system from Heidelberg Engineering GmbH (Heidelberg, 
Germany) was used. The HRA I device features lasers in the short (visible) wavelength 
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range (488 nm and 514 nm), and also in the long (infrared) wavelength range (785/815 nm). 
The 488 and 795 nm lasers are used for fluorescein (FLA) and indocyanine green (ICG) 
angiography, respectively. GFP excitation was detected in the autofluorescence mode at 488 
nm with a 500 nm barrier filter.  
 
1.4.2. Optical coherence tomography (OCT) 
 
OCT is a retinal imaging technology that provides micrometer-scale, cross-sectional imaging 
in biological systems (Fujimoto et al. 1995, Drexler et al. 2001, Fujimoto 2003). In 
ophthalmology, it is used to assess the thickness, morphology, and vascular layers of the 
retina and choroid of healthy and diseased eyes. OCT is a non-invasive imaging method that 
uses low coherence reflectometry to obtain cross-sectional images of the retina on a 
micrometer scale by measuring the echo time delay and intensity of the reflected and 
backscattered light (Frohman et al. 2008).  
 
OCT acquires all information in one single axial scan simultaneously by evaluating the 
frequency spectrum of the interference between the reflected light and a stationary reference 
mirror. Therefore, the interference pattern is decoded and split into its frequency components 
by a Fourier transformation. Each detected frequency corresponds to a certain depth within 
the tissue, and all of these components are simultaneously detected. The use of broadband 
light sources instead of low-coherent ones enables a higher depth resolution (Born and Wolf 
1999, Drexler et al. 2001). Commercial OCT is one of the new standards for in vivo non-
invasive ophthalmic imaging and is widely used for diagnosis and treatment monitoring of 
various ocular diseases in humans and experimental assets (Ruggeri et al. 2007). Several 
companies have commercialized stand-alone units and a third generation system from 
Heidelberg Engineering (Spectralis™, Heidelberg Engineering GmbH, Heidelberg, Germany) 
combining spectral-domain OCT with angiography has been used for this thesis.  
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2. AIMS OF THE STUDY 
 
In this thesis, I address our contribution to the understanding of the mechanisms of the 
pathophysiology associated with inherited retinal diseases (genes marked with red). This 
particularly concerns an early-onset form of RP called Leber’s Congenital Amaurosis (LCA) 
and two photoreceptor channelopathies that affect the rod and the cone system, respectively. 
A further part of the work concerns corresponding therapeutic approaches we have 
established and the development of novel structural in vivo biomarkers for the follow-up of 
the therapeutic outcome. Because the full course of the disease is difficult to analyze in 
patients, respective transgenic animal models were studied for this work. 
 
 
 
 
Figure 5. Clinical symptoms of non-syndromic monogenic retinal and vitreoretinal diseases and their 
causative genes (modified from (Berger et al. 2010) update 2014). 
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3. RESULTS 
 
3.1. MANUSCRIPTS INCLUDED IN THIS THESIS 
 
Paper I Loss of CRB2 in the mouse retina mimics human retinitis pigmentosa due to 
mutations in the CRB1 gene. Alves CH, Sanz AS, Park B, Pellissier LP, 
Tanimoto N, Beck SC, Huber G, Murtaza M, Richard F, Sridevi Gurubaran I, 
Garcia Garrido M, Levelt CN, Rashbass P, Le Bivic A, Seeliger MW, 
Wijnholds J. (2013) Human Molecular Genetics; 22(1):35-50. 
 
Paper II Targeted ablation of CRB1 and CRB2 in retinal progenitor cells mimics Leber 
congenital amaurosis. Pellissier LP, Alves CH, Quinn PM, Vos RM, Tanimoto 
N, Lundvig DM, Dudok JJ, Hooibrink B, Richard F, Beck SC, Huber G, 
Sothilingam V, Garcia Garrido M, Le Bivic A, Seeliger MW, Wijnholds J. 
(2013) PLOS Genetics; 9(12):e1003976. 
 
Paper III Gene therapy restores vision and delays degeneration in the CNGB1(-/-) 
mouse model of retinitis pigmentosa. Koch S, Sothilingam V, Garcia Garrido 
M, Tanimoto N, Becirovic E, Koch F, Seide C, Beck SC, Seeliger MW, Biel M, 
Mühlfriedel R, Michalakis S. (2012) Human Molecular Genetics; 21(20):4486-
96. 
 
Paper IV Optimized technique for subretinal injections in mice. Mühlfriedel R, Michalakis 
S, Garcia Garrido M, Biel M, Seeliger MW. (2013) Methods in Molecular 
Biology; 935:343-9. 
 
Paper V Towards a quantitative OCT image analysis. Garcia Garrido M, Beck SC, 
Mühlfriedel R, Julien S, Schraermeyer U, Seeliger MW. (2014) PLOS One; 
9(6):e100080. 
 
Paper VI Two-dimensional measurements in OCT images. Garcia Garrido M, 
Mühlfriedel R, Beck S, Wallrapp C, Seeliger MW (2015) PLOS One. Accepted 
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3.2. Part I: Rodent models of RP based on Crumbs protein deficiency 
 
3.2.1. Background (Paper I and II) 
The Crumbs (CRB) protein complex locates to the subapical region adjacent to the 
adherence junctions between photoreceptors and Müller glia cells and plays a critical role in 
the establishment and maintenance of the apico-basal polarity in photoreceptor cells 
(Mehalow et al. 2003, van de Pavert et al. 2004, van de Pavert et al. 2007b). In mammals, 
the CRB family consists of four members: CRB1, CRB2, CRB3A and CRB3B. The Crb 
protein is a transmembrane protein with a large extracellular domain with epidermal growth 
factor (EGF) and laminin-globular domains, a single transmembrane domain, and an 
intracellular C-terminus of 37 amino acids with single FERM and PDZ protein-binding motifs 
(Tepass et al. 1990). In the adult mouse retina, CRB2 is present in photoreceptors and 
Müller glia cells, whereas CRB1 protein is only expressed in Müller glia cells (van Rossum et 
al. 2006). Mutations in the human CRB1 gene cause autosomal-recessive Retinitis 
Pigmentosa and Leber’s Congenital Amaurosis (Richard et al. 2006). In previous studies, it 
was demonstrated that in Crb1 knockout (Crb1-/-) mice, the loss of CRB1 expression led to 
photoreceptor displacement and was accompanied by the appearance of (half-) rosettes due 
to focal loss of adhesion between photoreceptors and Müller glial cells in the inferior 
quadrant of the retina (van de Pavert et al. 2004, van de Pavert et al. 2007a). Based on 
these investigations, we studied the effects of the loss of CRB2 in the mouse (Paper I) as 
well as the simultaneous loss of CRB1 and CRB2 and their potential overlapping functions 
(Paper II).  
 
3.2.2. Results (Paper I) 
A conditional Crb2 knock-out (cKO) mouse driven by the Chx10 promoter was generated by 
our collaboration partners in Amsterdam and it was later in vivo functionally and 
morphologically characterized here in Tübingen. Heterozygous mutant mice were examined 
up to 18 months of age by means of electroretinography as well as SLO and OCT imaging. 
However, we did not find any differences in comparison to control animals (Fig 2 and 3, 
Paper I). In contrast, we found that Crb2Chx10 cKO mice had already at the age of 1 month 
an impairment of retinal function, depicting a strong photoreceptor dysfunction. Examinations 
were performed at several timepoints and we could show that with age, the amplitude of the 
signals further decreased and was severely reduced at 18 months (Fig 2, Paper I). During 
the in vivo morphological assessment we found several fundus abnormalities, and in contrast 
to the previously reported Crb1 mouse (van der Pavert et al. 2004), these effects were seen 
along the fundus. At the age of three months, mice presented a spotty fundus which turned 
into larger lesion areas with increasing age. We also visualized several hypo- and 
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hyperflourescent areas correlating with the presence of lipofuscin, whose presence is an 
indicator of retinal degeneration. In the angiographical work-up, we further detected 
fluorescein leakages which are usually related to sites of neovascularization. The retinal 
structure looked significantly disturbed: we observed several misplaced cells and an 
important loss in the retinal thickness was further visualized (Fig 4, Paper I). Histological 
analyses were later performed and they correlated well with our in vivo findings. In addition, 
disruptions in the outer limiting membrane, rosettes and ectopic nuclei in the subretinal 
space could be also detected (Fig 5, Paper I). In the immunohistochemistry analysis we 
observed an increase in GFAP expression and an abnormal expression of SOX9 and 
glutamine synthetase, indicating the presence of activated Müller glia cells (Fig 6 and 7, 
Paper I).  
Taken together, our data suggested that the retinal CRB2 protein plays important roles in 
maintaining the cell adhesion, photoreceptor polarity and retinal lamination. The progressive 
retinal degeneration described in depth in this study mimics that of Retinitis Pigmentosa due 
to mutations in the CRB1 gene. 
 
3.2.3. Results (Paper II) 
A Crb1Crb2 double knock-out (DKO) mouse was generated in Amsterdam and we assessed 
the retinal function and morphology over time. In this case, whereas the Crb2 deficient 
mouse was a conditional knock-out (cKO) driven by the Chx10 promoter, the Crb1 was a 
constitutive KO mouse. In these DKO mice, we found that the ERG responses were 
decreased from the very first examination point and were rapidly no more detectable at the 
age of 3 months (Fig 1, Paper II). However, progression of the degeneration was followed 
until later stages and in parallel, we further characterized the combination of the different 
genetic variants of the Crb1 and Crb2 proteins (Crb2-/-Chx10-Cre, Crb2+/-Chx10-Cre, Crb1-/-
Crb2+/-Chx10Cre, Crb1-/-Crb2-/-Chx10Cre, Crb1+/-Crb2-/-Chx10Cre and Crb1+/-Crb2+/-
Chx10Cre). The effects of the simultaneous deficiency of Crb1 and Crb2 proteins were also 
studied by in vivo retinal imaging. Striking results were observed by OCT imaging, where we 
visualized an abnormally thick retina with an aberrant layering, very similar to that of CRB1-
LCA patients (Fig 3, Paper II). However, retinal thickness promptly decreased already at the 
age of 3 months and a further reduction was visualized at the age of 6 months. SLO imaging 
depicted a strongly degenerated fundus and large areas of fluorescent material were 
detectable in the autofluorescent mode (Fig 3, Paper II). Using specific markers for the 
different cell types, it was found that all cell types formed although several of them localized 
ectopically (Fig 5, Paper II). Furthermore, quantification of cleaved caspase 3 positive cells 
showed an increase in the number of apoptotic cells (Fig 6, Paper II). 
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In summary, our data showed that levels of CRB protein control the lamination and 
proliferation of progenitor retinal cells and further demonstrate that Crb1 and Crb2 proteins 
may have overlapping functions. The unique clinical features displayed by this model imitate 
well the human LCA due to mutations in the CRB1 gene. 
 
3.2.4. Contribution to Paper I and II 
For this work, I performed the in vivo morphological analysis by means of SLO and OCT in 
all of the Crumbs mutant variants (Crb2-/-Chx10-Cre, Crb2+/-Chx10-Cre, Crb1-/-Crb2+/-
Chx10Cre, Crb1-/-Crb2-/-Chx10Cre, Crb1+/-Crb2-/-Chx10Cre and Crb1+/-Crb2+/-Chx10Cre). 
Animals groups of 3-5 animals were examined at the age of 1, 3, 6, 12 and 18 months. I also 
analysed the data and contributed on writing respective manuscripts, their revised versions 
until their final acceptance.   
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3.3. Part II: Development of morphological biomarkers for the short– and long term 
assessment of therapeutic effects (Summary of Paper III and IV) 
 
3.3.1. Background (Paper III and IV) 
Cyclic nucleotide-gated (CNG) channels locate to the plasma membrane of rod and cone 
photoreceptors and play a very important role in the phototransduction cascade. The cone 
CNG channel is a heterotetramer composed of two CNGA3 and two CNGB3 subunits 
whereas the rod CNG channel is formed by three CNGA1 and one CNGB1 subunit (Biel and 
Michalakis 2007).  
Mutations in the genes that encode either CNGA3 or CNGB3 subunits account together for 
~75% of all cases of complete Achromatopsia. Achromatopsia is a hereditary autosomal 
recessive disorder characterized by a total lack of cone photoreceptor function. 
Achromatopsia patients suffer from colour blindness, poor visual acuity, nystagmus, and 
photophobia (Michalakis et al. 2010). Mutations in the CNGB1 subunit are found in about 4% 
of the patients with autosomal recessive Retinitis Pigmentosa (arRP) (Hartong and Kooijman 
2006). Classical clinical symptoms of Retinitis Pigmentosa have been already described in 
detail in the Introduction Chapter of this thesis.  
Since the clinical impact of both diseases is very high and a vast knowledge is available, it is 
for this reason that our group has been working in the last years towards a retinal gene 
therapy which can restore the function and morphology in a mouse model of Achromatopsia 
and Retinitis Pigmentosa, lacking the Cnga3 and Cngb1 proteins, respectively. The first 
milestone was already addressed and it included a rAAV-mediated gene replacement 
strategy in the Cnga3 deficient mouse. In this work, we decided to deliver our viral vector via 
subretinal injection since our target were the photoreceptors and it resulted that after this 
approach not only photoreceptors cells were functionally rescued but also the functionality at 
ganglion cell level was restored, which implied that the visual information was sent to the 
brain (Michalakis et al. 2010). 
Since the outcome of a gene therapy in short- and long term is highly influenced by vector 
administration procedures it is necessary to ensure a good practice in this type of 
approaches. These aspects are included in the second part of this thesis.  
 
3.3.2. Results (Paper III) 
In this work, we described our methodology for optimized subretinal injections on the base of 
the Cnga3 gene therapy (Fig 1, Paper III) and defined structural biomarkers for the 
assessment of the intervention in the short time (Fig 2, Paper III). Subretinal injections took 
place in anesthetized animals and ten minutes after injection, we performed SLO and OCT 
examinations which allowed for a non-invasive in vivo visualization of the retinal structure. 
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Firstly, SLO allowed us to assess the overall integrity of the anterior and posterior part of the 
eye. Should a mouse have some primary ocular defects (e. g. developmental), the animal 
could have been excluded from our study. Furthermore, the exact location of the injected 
material in the fundus in reference to the location of the injection bleb became visible (Fig 2, 
Paper III). This is of high importance due to the anatomical properties of the retina (e.g. cell 
distribution, opsin gradient, etc). Besides, we could rule out adverse effects such as retinal 
detachment (due to an excess of the injected amount) or haemorrhages (due to vascular 
damage). 
OCT imaging provided us with additional information in regard of the retinal layer 
composition. The acquired data served to allocate the injection within the layers, for instance, 
we could distinguish between subretinal and intravitreal injections. Additionally, we were able 
to visualize the height of the injection bleb and the size of the transduced area (Fig 2, Paper 
III).  
After defining our structural biomarkers, we then established and applied new criteria for the 
performance of this kind of approaches. These biomarkers complement well with other 
established techniques such as histology and electroretinography and provide the study with 
valuable information about the current appearance of the retina and influence the course of 
the selected approach. 
 
3.3.3. Results (Paper IV) 
This work is a joint project between our collaboration partners in Munich and our lab in 
Tübingen. Our aim here was to restore the functionality as well as the morphology in the 
Cngb1 mouse, a RP model, and define novel in vivo structural biomarkers which may be 
used in the assessment of long time effects of therapeutic interventions.  
This treatment was done similarly to the Cnga3 gene therapy based on subretinal application 
of rAAVs (Koch et al. 2012). For this purpose, a specific viral vector was designed in Munich 
and we injected it subretinally in young Cngb1 mice. The injection site was directly in vivo 
monitored 10 minutes after injection and respective structural biomarkers in the short term 
were considered (Paper III). Later, the course of our intervention was followed at several 
post-injection timepoints by means of retinal imaging and electroretinography (Fig 3 and 4, 
Paper IV). Here, based on the retinal layering visualized by OCT, we were able to distinguish 
between a treated and an untreated region within the same eye, meaning that with a single 
vector application we were able to transfect one third of the retina (Fig 3, Paper IV). These 
findings correlated well with subsequent protein expression analyses and further revealed 
that the protein was mostly located to the rod outer segment, suggesting that our approach 
restored the correct expression and localization of the CNG channel. (Fig 2, Paper IV). 
Within transfected (treated) areas, a proper retinal lamination was found in comparison to 
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non-transfected areas and/or untreated eyes (which served as control). Furthermore, in the 
functional assessment, we found significant differences between the treated and the 
untreated eye, and we reported a substantial increase in the b-wave amplitude especially at 
low light intensities (Fig 4, Paper IV). These rescue effects were of course proportional to 
that of the extension of the injected area. Finally, we performed a behavioural test to check 
whether the ERG responses were forwarded to the brain and we obtained positive results 
(Fig 5, Paper IV). Rescue effects were further under observation until the age of 12 months 
and confirmed our established morphological biomarkers in the long term. We were 
additionally able to show, as typical of RP models where cones degenerate secondary to 
rods, that cone photoreceptors at least in part benefit from the effects of the rod rescue (Fig 
6, Paper IV). 
In order to standardize and convert the information provided by long term biomarkers into 
numerical data, I attempted to process the information contained in the OCT image data 
(Paper V). For this, I plotted the reflectivity values (in form of pixel intensity in a greyscale) vs. 
depth (in terms of OCT, a so-called A-scan) at one specific location. As location, I chose the 
treated vs. untreated areas (or vs. the untreated eye). With this procedure, each OCT band 
can be correlated with a retinal layer, and valuable details such as size and tissue-specific 
reflective properties may be obtained. Within effectively treated areas, an additional OCT 
band was distinguishable in comparison to that of untreated areas. This band represented 
the border between the inner and outer segment of the photoreceptor (I/OS). In the untreated 
eye this band was significantly smaller or missing. This means that the organization of the 
outer retina partially recovered in treated areas in comparison to an untreated eye. This 
information was compiled and presented in Paper V of this thesis. 
 
3.3.4. Contribution to Paper III and IV 
The work in Paper III highlights the value of morphological analyses shortly after subretinal 
injection as well as at 2, 4, 8 and 12 months of age, using several vectors and/or other 
regulatory elements. Furthermore, I also contributed with substantial text passages to both 
manuscripts (Paper III & IV). During the data collection for Paper III, I assisted Dr. 
Mühlfriedel with the subretinal injections. After analyzing the data, I designed the structural 
biomarkers described above, which set up the basis for my subsequent work to improve the 
understanding and follow up of retinal gene therapy.  
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3.4. Part III: Development of morphological biomarkers beyond the state-of-the-art 
of the diagnostic technology 
 
3.4.1. Background (Paper V) 
In the past, fundus photography and angiography have been the traditional imaging 
techniques in order to assess macroscopic changes in retinal disease, whereas histology 
and immunohistochemistry were chosen with the aim of visualize fine details ex vivo. 
Therefore, it was a major breakthrough in ophthalmic diagnostics when OCT was first 
introduced as a novel tool for in vivo visualization of retinal layers (Fujimoto et al. 1995, 
Drexler et al. 2003). The resolution of third generation models of OCT equipment that 
became available a few years later finally turned out to be sufficient for use in rodent models 
of retinal disease (Fischer et al. 2009). This is of particular advantage for experimental 
research since it gives the option to follow the course of disease and/or monitor the effects of 
a therapeutic intervention over time in individual eyes (Ruggeri et al. 2007, Fischer et al. 
2009). Technically, OCT provides cross-sectional images based on the reflective properties 
of the investigated sample (Fujimoto et al. 1995). A single measurement of the reflectivity 
versus depth at one specific location is called A-scan, whereas the composition of an image 
by alignment of several consecutive A-scans is called B-scan (van Velthoven et al. 2007). A 
typical B-scan shows several, often alternating bands of low and high reflectivity, as 
plexiform layers have a higher level of reflectivity than nuclear layers (Jacobson et al. 2003). 
However, these bands and the retinal layers associated with them vary in their extent with 
the topographical position in the retina, and this is additionally species-dependent as 
mentioned above. Besides, automated segmentation procedures have still not reached a 
satisfactory level of performance, which is why in the majority of cases simply a qualitative 
evaluation is performed. In order to address these issues, we attempted to investigate the 
retinal structure by means of OCT reflectivity profiles in a number of experimental models 
commonly used in research. 
 
3.4.2. Results (Paper V) 
In this work, we used the layer reflectivity in OCT images as a function of scan depth (similar 
to A-scan data) for a quantitative analysis of the retina of three laboratory species with a 
different degree of topographic structuring (Figs 1-4, Paper V). These species included: Mus 
musculus (mouse), Meriones unguiculatus (gerbil) and Macaca fascicularis (cynomolgus 
monkey). Firstly, we started with the less topographically structured retina, which belonged to 
the mouse. Since it was already reported that within the mouse retina several anatomical 
differences are found (e.g. cell distribution, opsin gradient) (Peichl et al. 2005), we wanted to 
know if those differences were visible in OCT. Since we found that along the retina all the 
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reflectivity profiles were practically identical, we were able to generate a standard reflectivity 
profile in the mouse where the retinal layers were easily identified (Supp Fig 1, Paper V). In 
the second place, we further compared two commonly used control mouse lines, the 
C57BL/6 line representing pigmented strains, and the BALB/c line representing non-
pigmented ones (Fig 2, Paper V). The difference between these both lines is the melanin 
content which locates mainly to the retinal pigmented epithelium and the choroid. Here, we 
found that variations in the pigment content do influence the detection of the underlying 
anatomical structures and their representation in the reflectivity profile. Albino animals 
showed a more detailed representation of the outer retina where structures like the 
choriocapillaries were visible (Fig 2, Paper V). Then we studied another rodent model, the 
gerbil. These animals are characterized by the presence of a visual streak (Huber et al. 
2010). In our representation, this region presented as an elongation of the crest 
corresponding to the photoreceptor outer segments (Fig 3, Paper V). In addition, SLO was 
complementary performed and here we observed a unique disposition of retinal vessels at 
the level of the visual streak, together with a hyperreflective representation of it in the normal 
native imaging mode (Fig 3, Paper V). Finally, we switched to a more specialised retina 
characterized by the presence of a fovea. This structure is limited to primates and is also 
present in the human eye. The reflectivity data acquired in the model allow to relate retinal 
layers in foveal and non-foveal regions to that of the human counterparts (Figs 4 and 5, 
Paper V), which further demonstrates the potential of this method. In conclusion, this work 
proofs that this kind of image processing method is valid for an inter-species evaluation of 
the data and may help to optimize OCT segmentation algorithms. 
 
3.4.3. Contribution (Paper V) 
As the first author of this manuscript, I designed the study and performed all experiments 
under the supervision of Prof. Seeliger In addition, I analysed the data and assembled the 
manuscript and its revision until final acceptance. 
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3.4.4. Background (Paper VI) 
OCT imaging plays a very important role in clinical ophthalmology. However, little progress 
has been made in the development of methods for exact calibration of OCT image data and 
it is maybe for this reason that most of the reported results are limited to qualitative data. 
Besides, interpretation of the data have been complicated within the last years in part due to 
the variety of OCT manufactures, as they all provide their own software (Wolf-Schnurrbusch 
et al. 2009, Sull et al. 2010). Additionally, differences in their segmentation algorithms on 
which retinal thickness measurements based on (Odell et al. 2011, Krebs et al. 2010), axial 
resolution in tissue (Folgar et al. 2014), scan density variations (Sadda et al. 2010) and 
anatomic variations between individual patients as well as inter-species (Cook et al. 2008, 
Huber et al. 2010) are the most reported obstacles to deal with in the development of 
methods for exact calibration of OCT image data. 
Several groups worldwide, including our group, verified retinal layer thickness in OCT scans, 
measured on a single dimension along the Y axis of images, on the basis of matching 
histological sections, and established respective correlation coefficients (Fischer et al. 2009, 
Huber et al. 2009, Ferguson et al. 2014). However, two-dimensional OCT images (B-scan) 
are generated via an alignment of separate one-dimensional scans (A-scan). In such B-
scans, the Y axis reflects properties of the scan, whereas the X axis is a product of internal 
post processing based on a number of inferences.  
Another approach that eliminates intra- and intersubject variabilities and provides new 
insights to the field is the use of a model eye. Agrawal and other groups worked towards the 
development of such an in vitro retina phantom for the evaluation of OCT devices (Zawadzki 
et al. 2010, Agrawal et al. 2012, Lozano et al. 2013). 
In this work, we were looking for a more direct and reliable way to obtain equal scales for X 
and Y in vivo that permit two-dimensional measurements in OCT images that are otherwise 
distorted.  
 
3.4.5. Results (Paper VI) 
For the realisation of this work, we based our approach on dimensionally stable alginate 
capsules (Cellbeads®) as an in vivo calibration tool. Since a spherical body has equal 
dimensions along the X, Y and Z axis, it appeared to be a suitable gauge for scaling. These 
beads contained human mesenchymal stem cells transformed to produce green fluorescent 
protein (GFP) and they were placed both in the subretinal and intravitreal space of murine 
eyes. Later, intravitreal as well as subretinal transplanted beads were visualized by means of 
SLO and OCT (Fig 3, Paper VI) and an estimation of the resulting scaling errors was 
provided (Fig 3, Paper VI). Based on those errors, a correction factor of about 3.3 was found 
for both subretinal and epiretinally located beads. Further, we developed a mathematical 
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description that allows to correct measurements of targets contained within an OCT scan in 
an arbitrary direction.  
We demonstrated this approach with the help of two examples of defined geometrical shapes. 
First, we addressed the behaviour of a circular shape assuming the same diameter along X 
and Y axes (a/b=1). When the scale of the X axis changes up to a radio of a/b=5, our circle 
became an ellipse. This effect will be therefore applicable to retinal structures like e.g. 
vessels which will then show an elliptical cross section in the OCT scan. And when 
attempting to measure the diameter of the structure, this is only straightforward at 0° or 90°, 
i.e. entirely along the X or Y axis. While in case of the (original) circle the diameter is 
independent of the angle of the section, this is not so in case of an ellipse (Fig 1, Paper VI). 
Depending on the angle of the section (α) and the ratio between X and Y scales (a/b), the 
measured result has to be divided by the relative diameter (dr) to reflect the correct distance. 
The second example was a rectangle at an angle of 45°, which could e.g. reflect a vessel 
running in the X-Y plane (Fig 2, Paper VI). Again, the scale of the X axis was changed up to 
ratio b/a=5. It is clear that a change in the scale of X will increase or reduce the angle of the 
structure; the actual formula for that angle being α=arctan(a/b). This effect will lead to an 
underestimation of the angle when the X scale is larger than the Y scale, and will be a 
particular problem for any analysis by visual inspection (Fig 5, Paper VI). 
The establishment of equal scales for OCT appears to be essential as it influences both 
qualitative and quantitative image analysis that often guides diagnosis and treatment in eye 
diseases. 
 
3.4.6. Contribution (Paper VI) 
For this work I performed all the experiments in mice and the analysis of the acquired data. I 
wrote the manuscript under the supervision of Prof. Seeliger and took care of the submission 
and revision until final acceptance. 
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4. DISCUSSION 
 
This thesis relates recent discoveries about the underlying mechanisms in common and very 
important retinal diseases such as an early onset form of RP called LCA and two 
photoreceptor channelopathies affecting either rod or cone cells. Other primary aspects 
treated in this thesis are the development of novel and more informative morphological 
biomarkers for use in the assessment of therapeutic intervention, and the diagnostic 
improvement and optimization of OCT technology.  
 
Mutations in the CRB1 gene have been described to cause RP and LCA. Mutations in CRB2 
have been also associated with the disease but so far, they have not been described as the 
single cause leading to disease (van den Hurk et al. 2005). The retina in CRB1-associated 
retinal degeneration patients is characterized by the lack of ordered retinal layers and is 
notably thicker than that of healthy subjects (Jacobson et al. 2003). However, the phenotype 
of a Crb1 KO mouse was very different to that of human patients. Although a retinal 
degeneration could be observed, this was only located to one quadrant of the retina and did 
not therefore represent the retinal degeneration seen in patients (van de Pavert et al. 2007b). 
These findings were confirmed later on the rd8-Crumbs mutant mouse in which the mutation 
(citosine deletion in Exon 9) occured naturally (Aleman et al. 2011). Our continuing 
investigations in the Crb2Chx10 mouse revealed novel aspects of the disease. This model 
developed an early retinal disorganization and retinal degeneration that extended all over the 
fundus and reminded of that of CRB1-related RP patients (Alves et al. 2013) (Paper I). It was 
then suggested that CRB2 had a more relevant role than CRB1, and that it was responsible 
for the correct retinal lamination and proliferation of progenitors. However, this aberrant 
retinal thickness found in patients could not be explained until we studied an additional 
mouse model: the Crb1Crb2 DKO (Pellissier et al. 2013) (Paper II). This mouse mimicked 
the human LCA phenotype in a much better way. The results obtained in these studies 
suggest that the severity of the disease in mice is inversely proportional to amount of Crb 
protein and, that Crb1 and Crb2 proteins might have overlapping functions, so that only a 
combinational DKO produces a human-like result.  
 
In both Paper I and II, we were able to report these important mechanistic insights to the 
pathophysiology of RP and LCA. Recently, by means of several genetic variants and/or new 
generated mutant mice, the role of the Crb1 and Crb2 protein was further studied as well as 
the role of other proteins which are also part of the Crumbs complex such as Mpp3. In those 
approaches, the protein expression was regulated by different specific promotors as for 
example the Crx (which targets both photoreceptor cell types) or the PdgFrα (for the MGC). 
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These results were reported in Manuscripts #9, 17 and 18 as listed at the end of this thesis. 
Since our mouse models had several similarities with the human disease, they offer great 
possibilities for the development of new therapeutic strategies. First steps to evaluate the 
potential of a therapy that restores retinal structure and function in a Crb1-RP model have 
been done already (Pellissier et al. 2015). In addition, in all of these studies we were able to 
demonstrate that SLO and OCT imaging are very useful diagnostic techniques in such 
projects. They are particularly well suited to follow the course of the disease together with 
functional in vivo techniques such as ERG. 
 
In Paper III, we focused on the description of structural biomarkers which serve for the 
evaluation of therapeutic strategies in the short term, as the localization of the injected 
material and the extension and height of the bleb after injection. This study was carried out in 
the framework of the Cnga3 gene replacement therapy. The performance of in vivo imaging 
techniques like SLO and OCT served as a quality control of subretinal injections and 
provided novel insights which can notably determine the course of the intervention in 
individual eyes. Besides, since examinations may be repeated in relatively short periods of 
time, a very accurate time course of the effects of an intervention (positive and adverse) may 
be recorded.  
In analogy, we defined relevant structural biomarkers for the Cngb1 gene replacement 
approach. Here, restoration of vision was obtained by means of an AAV-based gene therapy 
in the CNGB1 knock-out model of RP (Koch et al. 2012) (Paper IV). Those biomarkers 
included differences in the appearances of the OCT bands as well as a comprenhensive 
quantitative analysis of the data contained in an OCT image. Furthermore, we introduced a 
way to use OCT reflectivity profiles for a quantitative description of retinal layers (Garcia 
Garrido et al. 2014) (Paper V). Taking into account that current developments of molecular 
therapies, particularly in retinal degenerations, will undoubtedly lead to a large number of 
clinical trials in the near future, the in vivo quantification of therapeutic effects over time will 
almost certanly include OCT data. 
Since visual inspection is usually sufficient to get an immediate overview of the contained 
information, this study has a broad application potential on both clinic and research. 
 
The third part of this thesis was devoted to the improvement and optimization of OCT as 
diagnostic technology. In the first place, we demonstrated the potential of OCT reflectivity 
profiles as a basis for a quantitative characterization of the retinal morphology in a cross-
species comparative study (Garcia Garrido et al. 2014) (Paper V). The characteristic pattern 
of the mammalian reflectivity profiles may also help to better fine-tune automated 
segmentation algorithms. It is a long-standing problem that, because retinal anatomy and 
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layering in health as well as in disease is complex and variable, automated segmentation 
procedures have not yet reached a satisfactory level of performance. Here it was shown that 
quantitative OCT analyses are very well suited to capture and numeralize similarities and 
differences in the retina of three laboratory species with a different degree of topographic 
structuring: mouse, gerbil and NHP. This work closely relates to human studies (Barthelmes 
et al. 2006, Barthelmes et al. 2008, Jacobson et al. 2009, Jacobson et al. 2012). As a first 
step in this study, we investigated whether the anatomical properties within the mouse retina 
would affect our reflectivity profile. Secondly, we studied whether differences in the retinal 
pigment content would somehow affect the reflectivity profile and therefore, we examined the 
C57BL/6 line representing pigmented strains, and the BALB/c line representing non-
pigmented ones. Besides, each part of the profile was matched to a corresponding retinal 
structure in ex vivo morphology. As presumed, we found that variations in the retinal pigment 
content do influence the detection of the underlying anatomical structures and their 
representation in the reflectivity profile. By acquiring several reflectivity profiles from different 
fundus locations, we could demonstrate that the comparatively minor topographical 
differences across the mouse retina (e.g. cell distribution, opsin gradient) did not 
substantially manifest in OCT reflectivity profiles. In a next step, we recorded a standard 
reflectivity profile of another rodent model, the gerbil. Gerbils are primarily diurnal (activity 
during the day and sleeping at night). Their body size lies between that of mice and rats, but 
their retinal organisation is very different from those primarily nocturnal species. Most 
obvious in this regard is the well-expressed visual streak, a specialized retinal region that 
resembles many features of the human macula (Huber et al. 2010). The visual streak is 
represented in the native fundus image as a high reflective band located to the dorsal part of 
the retina. Based on the reflectivity profile, we were able to show that the visual streak region 
is characterized by an elongation of the crest corresponding to the photoreceptor outer 
segments. Another typical landmark in gerbils is the characteristic pattern of the retinal 
vasculature. The relatively high similarity of the vascular organization with the human macula 
may render this class of rodents suitable models for experimental therapies in diseases with 
a strong vascular component like Diabetes Mellitus. It is believed that the topographical 
differences in retinal morphology between different animal species have developed due to 
evolutionary pressure in their natural habitat. The driving force may be an advantage in the 
acquirement and processing of specific, vital visual information. Typical patterns associated 
with such an adaptation may include a difference in the number and type of retinal cells (e.g. 
photoreceptors, bipolar, or ganglion cells), the distribution and spectral sensitivity of visual 
pigments, or even variations in the vascular pattern (Peichl 2005). It is believed that 
preferential day- or night-activity constitutes a major determinative factor in this context, and 
whether the animal’s role is rather prey or predator. Indeed, other day-active species like the 
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unstriped soudanian grass rat (Arvicanthis ansorgei) are known to possess a retina rich in 
cones and a special organisation of those in the ONL (Boudard et al. 2010), very well in 
agreement with our findings. More details regarding the visual streak organisation in a 
predator like the cat with a so-called area centralis may be found elsewhere (Narfstrom et al. 
2011). Finally, we turned to even further specialised retinas as found in primates including 
humans. These retinae are characterized by the presence of a fovea conferring high-acuity 
central vision. Based on Cynomolgus monkey data, we produced a generic OCT reflectivity 
profile in non-human primates. All layers in foveal and non-foveal regions were successfully 
matched with that of human counterparts. Also, the foveal reflex, featuring a total reflection, 
was detected in both primates and humans. The quantification of the retinal nerve fibre layer 
(RNFL) via reflectivity profiles pointed out a lower density of nerve fibres in cynomolgus 
monkeys in comparison to human retina. In diseases where the thickness of the NFL is 
altered (e.g. glaucoma), the assessment of the RNFL via reflectivity profiles may 
nevertheless be a valuable biomarker in the follow-up of the disease. 
 
The final part of this thesis addresses the problems in OCT image analysis induced by 
distortion due to unequal X and Y scales, and provides an exemplary case for an OCT image 
calibration based on in vivo data using intraocular objects (Paper VI, Garcia Garrido et al. 
2015, accepted). The introduction of the OCT in the clinical practice has without question 
been one of the major breakthroughs of the recent years. A particular asset of imaging data 
in general is that a visual inspection is usually sufficient to get an immediate overview of the 
contained information without the need for an often intransparent numerical analysis. OCT 
data, however, have the appearance of histological sections, but they are generated quite 
differently. They are computer-generated images made of a lateral combination of a series of 
axial reflectivity profiles (A-scans). While the Y axis basically reflects the original A-scans, the 
X axis is a product of a fitting process based on a number of inferences, so that the scales 
for X and Y are not intrinsically identical. As scaling properties may be altered by factors like 
additional lenses in the optical pathway (on the equipment side or on the side of the subject), 
shape and size of the eye, or species differences (in experimental studies), a check of these 
properties may be required to ensure a system with equal scaling in X and Y (and possibly Z 
for ‘volume scan’ 3D stacks). It may be for this reason that two-dimensional measurements in 
OCT images, in contrast to e.g. ultrasound image data, are rarely used so far. 
The evaluation of OCT data is in the vast majority of clinical applications done by visual 
inspection, and to a lesser degree also supported by quantitative analysis. Presumably since 
unequal scales are not part of the natural environment, our visual system is not well suited to 
incorporate this in the assessment process. We show here that a number of effects may lead 
to unwanted distortions if the scales for X and Y are not equal, which may influence any 
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conclusions drawn from such images. The effect of distorted proportions in a two-
dimensional graph is demonstrated in this work on the basis of two examples. We showed 
that a circular shape turns into an ellipse if X-Y scaling is not equal. A two-dimensional 
measurement of such a distorted structure would require a correction dependent on the 
angle of the cross-section as detailed in Appendix 1 (Paper VI). Further, any rectangular 
structure will appear at an altered angle in the X-Y plane depending on the amount of scale 
differences, according to the formula given that determines the size of this effect and may be 
used for a correction.  As a conclusion, we proposed to establish an equal scaling of the 
axes to circumvent the need for any correction of distortion, which would both apply to visual 
inspection as well as to numerical two-dimensional measurements. To achieve a two-
dimensional calibration of the acquired OCT raw images, a relation between X and Y axis 
data needs to be established, which in our hands is most reliable when using well-defined 
intraocular objects in vivo. Potentially, this can be anything temporary or persistent from 
surgical equipment tips, syringes, or fluid droplets to implanted devices like slow release 
containers or retinal prostheses. The use of natural landmarks like the optic disc has the 
limitation that their exact size and shape is usually not known and may thus not work as 
desired. In this study, we use spherical MicroBeads containing GFP-expressing 
mesenchymal stem cells placed either sub- or epiretinally in the retina of Sv129 wild-type 
mice. We feel that an in vivo verification of scaling is the best option to ensure a proper 
calibration, as the complexity of the different tissues and pathways are hard to fully integrate 
in theoretical models or fabricated OCT phantoms (Agrawal et al. 2012, Baxi et al. 2014). 
For our setup, a correction factor of about 3.3 was determined from that data.  This factor 
describes the X-Y scaling differences within the same OCT scan and should not be confused 
with the “conversion constants” between OCT data and histology that have been established 
in several studies on animal models (Fischer et al. 2009, Huber et al. 2009, Ferguson et al. 
2014). These studies purely compare the A-Scan data (Y axis) with ex vivo tissue 
morphometry, whereas the present study is to our best knowledge the first to introduce a 
method of how a reliable X-Y relationship may be established based on real world data. Our 
results demonstrated the need for a proper two-dimensional calibration of OCT data, and we 
expect that the consideration of equal scaling will advance the use of two-dimensional 
measurements and thereby help to increase the efficiency of OCT image analysis. 
 
In summary, this thesis demonstrates the capability of in vivo retinal imaging techniques to 
unravel meaningful aspects of the retina in health and disease. Additionally, our work 
contributed to the further optimization and advancement of the diagnostic technology.   
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